MiCo BioMed Co., Ltd.

Equities

A214610

KR7214610008

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-30 EDT			5-day change	1st Jan Change
1,386 ^KRW	+1.32%		-1.70%	-25.16%

2023	MiCo BioMed Co., Ltd.(KOSDAQ:A214610) dropped from S&P Global BMI Index	CI
2023	Miko Co., Ltd. entered a stock purchase contract to acquire an additional 2.77% stake in MiCo BioMed Co., Ltd. from KoMiCo Ltd. for KRW 2.6 billion.	CI

Speclipse, Inc. announced that it has received $7.7 million in funding from S'ignite Partners Co., Ltd., BNH Investment LLC, Shinhan Capital Co., Ltd., MiCo Ltd., MiCo BioMed Co., Ltd.

August 18, 2021

Speclipse, Inc. announced that it has received $7,700,000 in a round of funding on August 19, 2021. The transaction included participation from S'ignite Partners Co., Ltd., BNH Investment LLC, Shinhan Capital Co., Ltd., MiCo Ltd, and MiCo BioMed Co., Ltd. The company has raised $13,000,000 in funding till date.

Latest news about MiCo BioMed Co., Ltd.

MiCo BioMed Co., Ltd.(KOSDAQ:A214610) dropped from S&P Global BMI Index	23-09-18	CI
Miko Co., Ltd. entered a stock purchase contract to acquire an additional 2.77% stake in MiCo BioMed Co., Ltd. from KoMiCo Ltd. for KRW 2.6 billion.	23-06-01	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 9 billion in funding	22-10-17	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 9 billion in funding	22-10-13	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 20 billion in funding	21-12-05	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 20 billion in funding	21-11-28	CI
MiCo BioMed Co., Ltd.(KOSDAQ:A214610) added to S&P Global BMI Index	21-09-20	CI
Speclipse, Inc. announced that it has received $7.7 million in funding from S'ignite Partners Co., Ltd., BNH Investment LLC, Shinhan Capital Co., Ltd., MiCo Ltd., MiCo BioMed Co., Ltd.	21-08-18	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 5 billion in funding	19-10-27	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 5 billion in funding	19-10-13	CI
MiCo BioMed Co., Ltd. cancelled the acquisition of Siloam Biosciences, Inc from a group of shareholders.	19-05-24	CI
MiCo BioMed Co., Ltd. agreed to acquire 98.3% stake in Siloam Biosciences, Inc from a group of shareholders for KRW 5.1 billion.	18-05-24	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 5 billion in funding	18-05-22	CI
Sunkyu Jeon acquired an additional 4.2% stake in MiCo BioMed Co., Ltd. from Sungwoo Kim for KRW 2.9 billion.	18-05-17	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 5 billion in funding	18-05-14	CI
Nanobiosys Inc. completed the acquisition of Micobiomed Co., Ltd. from MiCo Ltd., Sun-Kyu Jeon, Byungseung Kang and others.	17-11-16	CI
MiCo NanoBioSys Co., Ltd.'s Equity Buyback announced on August 31, 2017 has expired.	17-10-30	CI
Nanobiosys Inc. announces an Equity Buyback.	17-08-31	CI
Nanobiosys Inc. authorizes a Buyback Plan.	17-08-30	CI
Nanobiosys Inc. signed a merger contract to acquire Micobiomed Co., Ltd. from MiCo Ltd., Sun-Kyu Jeon, Byungseung Kang and others for KRW 35.3 billion.	17-08-30	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 3.5497125 billion in funding	16-04-28	CI

Chart MiCo BioMed Co., Ltd.

Duration

Period

More charts

Company Profile

MiCo BioMed Co Ltd, formerly MiCo NanoBioSys Co Ltd, is a Korea-based company mainly engaged in developing in vitro diagnostic (IVD) medical equipments and devices. The Company operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostics, anemia meters, blood glucose meters, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
MICO BIOMED CO., LTD.	-25.16%	43.64M
SARTORIUS AG	-37.33%	14.23B
QUIDELORTHO CORPORATION	-57.50%	2.12B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+23.17%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-18.13%	1.36B
BIOTAGE AB	+19.52%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-31.31%	789M
REVENIO GROUP OYJ	+0.52%	779M
CONTEC MEDICAL SYSTEMS CO.,LTD	-37.37%	714M
VAREX IMAGING CORPORATION	-29.61%	584M

Medical Diagnostic & Testing Equipment